Public trial registry of the CCC-Munich

Trial AFLIBC06097

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AFLIBC06097
World
Full title
:

A Multicenter, Single arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients with Metastatic Colorectal Cancer (mCRC) Previously Treated with an Oxaliplatin-Containing Regimen

World
EudraCT number
:
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551 Lmu
Indications
Classification Code Description
ICD-10-GM C19 Bösartige Neubildung am Rektosigmoid, Übergang
- Gastrointestinal tumors
- Colorectal carcinoma
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
III
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.